1. Home
  2. PRTA vs EGY Comparison

PRTA vs EGY Comparison

Compare PRTA & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • EGY
  • Stock Information
  • Founded
  • PRTA 2012
  • EGY 1985
  • Country
  • PRTA Ireland
  • EGY United States
  • Employees
  • PRTA N/A
  • EGY N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • EGY Oil & Gas Production
  • Sector
  • PRTA Health Care
  • EGY Energy
  • Exchange
  • PRTA Nasdaq
  • EGY Nasdaq
  • Market Cap
  • PRTA 366.6M
  • EGY 389.8M
  • IPO Year
  • PRTA N/A
  • EGY N/A
  • Fundamental
  • Price
  • PRTA $7.69
  • EGY $3.76
  • Analyst Decision
  • PRTA Buy
  • EGY
  • Analyst Count
  • PRTA 10
  • EGY 0
  • Target Price
  • PRTA $24.29
  • EGY N/A
  • AVG Volume (30 Days)
  • PRTA 955.8K
  • EGY 715.6K
  • Earning Date
  • PRTA 08-04-2025
  • EGY 08-07-2025
  • Dividend Yield
  • PRTA N/A
  • EGY 6.66%
  • EPS Growth
  • PRTA N/A
  • EGY N/A
  • EPS
  • PRTA N/A
  • EGY 0.37
  • Revenue
  • PRTA $10,341,000.00
  • EGY $469,277,000.00
  • Revenue This Year
  • PRTA N/A
  • EGY N/A
  • Revenue Next Year
  • PRTA $122.46
  • EGY $24.62
  • P/E Ratio
  • PRTA N/A
  • EGY $10.24
  • Revenue Growth
  • PRTA N/A
  • EGY N/A
  • 52 Week Low
  • PRTA $4.32
  • EGY $3.00
  • 52 Week High
  • PRTA $23.66
  • EGY $6.82
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 70.62
  • EGY 52.65
  • Support Level
  • PRTA $6.61
  • EGY $3.54
  • Resistance Level
  • PRTA $8.01
  • EGY $3.77
  • Average True Range (ATR)
  • PRTA 0.40
  • EGY 0.13
  • MACD
  • PRTA 0.10
  • EGY -0.01
  • Stochastic Oscillator
  • PRTA 81.40
  • EGY 55.00

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.

Share on Social Networks: